A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
10/1998
10/28/1998	EP0873750A1 Bioadhesive tablets
10/28/1998	EP0873749A1 Jellied medicinal composition for oral administration
10/28/1998	EP0873415A1 Fusion protein delivery system and uses thereof
10/28/1998	EP0873414A1 Galactopyranosides and their use
10/28/1998	EP0873407A1 Apo-2 ligand
10/28/1998	EP0873141A1 Compositions and methods for therapeutic use
10/28/1998	EP0873140A2 Immunoconjugate for the treatment of aids
10/28/1998	EP0873139A1 Antibodies with reduced net positive charge
10/28/1998	EP0873138A2 Improved pharmaceutical compositions
10/28/1998	EP0873130A2 Compositions comprising pvp having an average molecular weight in the range of 3.000 to 14.000 daltons
10/28/1998	EP0873129A1 Anion exchange resin-containing tablets
10/28/1998	EP0873127A1 Anthelmintic macrocyclic lactone compositions
10/28/1998	EP0873115A1 Preparation of tablets comprising a combination of active pellets, deformable pellets and disintegratable pellets
10/28/1998	EP0873114A1 Granulates for cosmetic and pharmaceutical preparations
10/28/1998	EP0873112A1 Skin care composition
10/28/1998	EP0804173B1 Controlled release biodegradable microspheres and method of preparation
10/28/1998	EP0734247B1 Cosmetic and/or pharmaceutical preparations
10/28/1998	EP0716648B1 New 9-chloro-prostaglandin derivatives
10/28/1998	EP0660687B1 Methods for providing localized therapeutic heat to biological tissues and fluids using gas filled liposomes
10/28/1998	EP0652746B1 Lymphatic delivery composition
10/28/1998	EP0407392B2 UNIQUE ANTIGENIC EPITOPES ON IgE-BEARING B LYMPHOCYTES
10/28/1998	CN1197456A Novel compsn. containing acid-labile benzimidazole and process for its prepn.
10/28/1998	CN1197396A Copolymeric micelle drug compsn. and method for the prepn. thereof
10/28/1998	CN1197395A Compsn. containing nerve fibre reactivity modulating compound
10/28/1998	CN1197387A Pharmaceutical compsns. of conjugated estrogens and methods for their use
10/28/1998	CN1196934A External-use skeleton powder and its prepn. method
10/28/1998	CN1196929A Production of solid combination drug forms
10/27/1998	US5827925 Polymeric material bonded to drug through ph-sensitive cleavable covalent bond
10/27/1998	US5827882 Method of using ethyl pyruvate for treating wrinkles
10/27/1998	US5827852 Coated pharmaceutical compositions
10/27/1998	US5827850 1,2,4-benzotriazine oxides formulations
10/27/1998	US5827835 Thermally-gelling emulsions
10/27/1998	US5827834 Method of using hyaluronic acid or its pharmaceutically acceptable salts for the treatment of disease
10/27/1998	US5827831 Lipid nucleotide analog prodrugs for oral administration
10/27/1998	US5827822 Aqueous suspension of cyclosporin particles and polyoxyethylene glycol surfactant
10/27/1998	US5827819 Pharmaceutical composition comprising a psychotropic, neurotropic or neurological drug, a polar lipid carrier, two linker functional groups and a spacer; facilitates entry of drugs into cells and tissues
10/27/1998	US5827737 Stable drosophila cell line
10/27/1998	US5827703 Methods and composition for in vivo gene therapy
10/27/1998	US5827536 Anticholesterol drug solution comprising a solubilizer nonionic surfactant diethylene glycol monoethyl ether
10/27/1998	US5827534 Oral dosage composition comprising zonnula occludens toxin and a therapeutic agent for intestinal delivery
10/27/1998	US5827520 Vehicle and composition containing this vehicle and a stabilized cosmetic or dermatological active substance
10/27/1998	CA2039869C Percutaneous-administration-type pharmaceutical preparation of nitroglycerin
10/22/1998	WO1998046648A1 Interactive system for substance presentation and elimination
10/22/1998	WO1998046274A2 Cationic polymers for nucleic acid transfection
10/22/1998	WO1998046270A2 Polymeric conjugates polyvalently presenting an agent for therapy
10/22/1998	WO1998046269A1 Permucous preparation
10/22/1998	WO1998046268A1 Medicinal composition
10/22/1998	WO1998046267A1 Base composition for percutaneous absorption and percutaneously absorbable preparation containing the base composition
10/22/1998	WO1998046261A1 Vaginal lactobacillus medicant
10/22/1998	WO1998046248A1 Method and material for inhibiting complement
10/22/1998	WO1998046239A1 Extended release formulations of erythromycin derivatives
10/22/1998	WO1998046237A1 Method of treating chronic progressive vascular scarring diseases
10/22/1998	WO1998046212A1 Biodegradable microparticles for the sustained delivery of therapeutic drugs
10/22/1998	WO1998046211A1 Sustained-release alginate gels
10/22/1998	WO1998046209A1 Use of microparticles having a protein and an antibody adsorbed thereon for preparing a pharmaceutical composition for intranasal administration
10/22/1998	WO1998046077A1 A method for treating papillomavirus infections
10/22/1998	WO1998002190A3 Cationic amphiphile/dna complexes
10/22/1998	DE19716154A1 Stabile pharmazeutische Darreichungsform für Peptide, Proteine und Nukleinsäuren The stable pharmaceutical dosage form of peptides, proteins and nucleic acids
10/22/1998	CA2465698A1 Extended release formulations of erythromycin derivatives
10/22/1998	CA2288968A1 Permucous preparation
10/22/1998	CA2287463A1 Base composition for percutaneous absorption and percutaneously absorbable preparation containing the base composition
10/22/1998	CA2286692A1 Polymeric conjugates polyvalently presenting an agent for therapy
10/22/1998	CA2285950A1 Method of treating chronic progressive vascular scarring diseases
10/22/1998	CA2285572A1 A method for treating papillomavirus infections
10/22/1998	CA2284988A1 Medicinal composition
10/21/1998	EP0872447A1 Silicon oxide powder and process for the production thereof, cosmetics made by using the same, micelle-retaining powder, and perfume-retaining powder
10/21/1998	EP0872249A1 Gene transfer preparation
10/21/1998	EP0872248A2 Pharmaceutical vehicles for reducing transdermal flux
10/21/1998	EP0872247A1 Pharmaceutical formulation
10/21/1998	EP0872243A1 Herb composition, herbal paste and herbal plaster made from the same
10/21/1998	EP0872236A1 Eye drops
10/21/1998	EP0872234A2 Laminar medical formulation
10/21/1998	EP0872232A1 Pharmaceutical preparation with delayed release of active ingredient
10/21/1998	EP0872231A1 Pharmaceutical compositions comprising lactobacilli suitable for trans-mucosal administration
10/21/1998	EP0871723A1 Somatic gene therapy to cells associated with fluid spaces
10/21/1998	EP0871721A1 A protein-lipid conjugate, consisting of heparin binding protein (hbp) and a ceramide analogue, and its pharmaceutical use in treatment of conditions involving stress injury to cells
10/21/1998	EP0871702A1 Cytokine designated lerk-7
10/21/1998	EP0871691A1 Process for purifying alkoxylated fats
10/21/1998	EP0871649A1 Conjugates of a polypeptide and a biocompatible polymer
10/21/1998	EP0871492A2 Mesothelium antigen and methods and kits for targeting it
10/21/1998	EP0871491A2 Polymers
10/21/1998	EP0871490A1 Branched hydrazone linkers
10/21/1998	EP0871489A1 A pharmaceutical composition for administration of an active substance to or through a skin or mucosal surface
10/21/1998	EP0871486A1 Diphtheria toxin epitopes
10/21/1998	EP0871481A1 Pseudomonas exotoxin as immunogenic carrier in synthetic conjugate vaccines
10/21/1998	EP0871476A1 Dried blood factor composition comprising trehalose
10/21/1998	EP0871467A1 Novel formulation for peptide release
10/21/1998	EP0871452A2 Sulfate conjugates of ursodeoxycholic acid, and their beneficial use in inflammatory disorders and other applications
10/21/1998	EP0871435A1 Sustained release formulation containing three different types of polymers
10/21/1998	EP0871434A1 Modified release oral pharmaceutical composition containing 5-asa and method for the treatment of bowel diseases
10/21/1998	EP0871433A2 Composition for sustained release of non-aggregated erythropoietin
10/21/1998	EP0871432A2 Biological agent compositions
10/21/1998	EP0871431A2 Hepatocyte-selective oil-in-water emulsion
10/21/1998	EP0871420A1 Triacetin as a transdermal penetration enhancer
10/21/1998	EP0738327B1 Host-vector system for use in gene therapy
10/21/1998	EP0651740B1 Amino acid linked nitrogen mustard derivatives and their use as prodrugs in the treatment of tumours
10/21/1998	CN1196676A Ophthalamic compositions containing cyclotextrins and quatemary ammonium composition
10/20/1998	US5824812 Polyfunctional cationic cytofectins, formulations and methods for generating active cytofectin: polynucleotide transfection complexes
10/20/1998	US5824805 Branched hydrazone linkers
10/20/1998	US5824784 Genetic engineering with polypeptides and proteins

1 ... 1449 1450 1451 1452 1453 1454 1455 1456 1457 1458 1459 1460 1461 1462 1463 1464 1465 1466 1467 1468 1469 ... 1712